Citation Impact
Citing Papers
Borrelia infection and risk of non-Hodgkin lymphoma
2008
Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy
2006 Standout
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Rodent-borne diseases and their risks for public health
2009 Standout
Immunoblot Analysis of Antibody Binding to Polypeptides of Borrelia burgdorferi in Children with Different Clinical Manifestations of Lyme Disease
1989
Animal antimicrobial peptides: An overview
1998 Standout
Clinical Manifestations and Diagnosis of Neuroborreliosis
1988
Lyme Disease
1989 Standout
Efficacy of antibiotic prophylaxis for prevention of lyme disease
1996
In vitro susceptibility of thirtyBorrelia strains from various sources against eight antimicrobial chemotherapeutics
1996
Lyme neuroborreliosis—epidemiology, diagnosis and management
2015
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema
2000
Seronegative Lyme Disease
1988
Chronic Lyme Disease: A Review
2008
Molecular diagnosis of Lyme disease: Review and meta-analysis
2001
Specific mRNA lipid nanoparticles and acquired resistance to ticks
2023 StandoutNobel
Anaplasma phagocytophilum—a widespread multi-host pathogen with highly adaptive strategies
2013 Standout
Atopic Dermatitis: Global Epidemiology and Risk Factors
2015 Standout
Complement activation in Lyme neuroborreliosis — Increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS
2006
European Lyme Borreliosis
1988
Primary Cutaneous B-Cell Lymphoma and Borrelia burgdorferi Infection in Patients From the Highlands of Scotland
2000
Phylogenetic Species Recognition and Species Concepts in Fungi
2000 Standout
Central Nervous System Manifestations of Lyme Disease
1989
Failure to isolate borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: Report of a prospective study
1993
Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children — A prospective study
1991
Western Blotting in the Serodiagnosis of Lyme Disease
1993 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
DIAGNOSIS AND TREATMENT OF LYME ARTHRITIS
1997
Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe
2010
Solitary borrelial lymphocytoma: Report of 36 cases
1992
Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR‐based study and review of the literature
2009
Nervous system Lyme disease
1998
Borrelia burgdorferi‐associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases
2004
Infection: friend or foe in the development of atopy and asthma?
2001
Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
1998 Standout
An Epidemiologic Study of Lyme Disease in Southern Sweden
1995
Failure of Treatment With Cephalexin for Lyme Disease
2000
Prevention of Lyme Disease after Tick Bites
1992
Kill kinetics ofBorrelia burgdorferi and bacterial findings in relation to the treatment of lyme borreliosis
1996
Neuropathy Associated with Acrodermatitis Chronica Atrophicans Clinical and Morphological Features
1988
Borrelia burgdorferi—associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization of four cases
1991
Laboratory Diagnosis of Lyme Disease
2015
TREATMENT OF LATE LYME BORRELIOSIS—RANDOMISED COMPARISON OF CEFTRIAXONE AND PENICILLIN
1988
Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden
2012
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
2001 Standout
Ticks and Tickborne Bacterial Diseases in Humans: An Emerging Infectious Threat
2001 Standout
Lyme borreliosis
2016
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys
2006 Standout
The VlsE (IR6) Peptide ELISA in the Serodiagnosis of Lyme Facial Paralysis
2004
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
2009
Interstitial granulomatous dermatitis with histiocytic pseudorosettes: A new histopathologic pattern in cutaneous borreliosis. Detection of Borrelia burgdorferi DNA sequences by a highly sensitive PCR-ELISA
2003
Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study
2002
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis
1995
Treatment of borrelial lymphocytoma
1996
Epidemiology of Lyme Disease
2015
Practice Guidelines for the Treatment of Lyme Disease
2000
Lyme borreliosis
1998
Clinical Pathologic Correlations of Lyme Disease by Stage
1988
Absence of Borrelia burgdorferi DNA in cutaneous B‐cell lymphomas from the United States
2001
Antigenic Variability of Borrelia burgdorferi
1988
Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents — Possible implications for new therapeutic approaches to Lyme disease
2002
Diagnostic Value of PCR for Detection of Borrelia burgdorferi DNA in Clinical Specimens From Patients With Erythema Migrans and Lyme Neuroborreliosis
2000
Lyme borreliosis
2003
Early Lyme Disease
2006
Chronic Neurologic Manifestations of Lyme Disease
1990
Lyme borreliosis
2011 Standout
Identification of Three Species of Borrelia burgdorferi Sensu Lato (B. burgdorferi Sensu Stricto, B. garinii, and B. afzelii) Among Isolates from Acrodermatitis Chronica Atrophicans Lesions
1998
Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis
1990
Amyotrophic Lateral Sclerosis
2001 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Erythema Migrans
2015
Microbiological and serological diagnosis of Lyme borreliosis
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin
1992
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease
1990
Clinical features and serology of 14 dogs affected by granulocytic ehrlichiosis in Sweden
1997
Clinical features of early erythema migrans disease and related disorders
1986
In Vitro Susceptibility Testing ofBorrelia burgdorferiSensu Lato Isolates Cultured from Patients with Erythema Migrans before and after Antimicrobial Chemotherapy
2005
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents
1990
Chronic Lyme borreliosis in the laboratory mouse.
1993
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice
1994
PCR inhibitors - occurrence, properties and removal
2012 Standout
Heterogeneity of Major Proteins in Lyme Disease Borreliae: A Molecular Analysis of North American and European Isolates
1985
Diagnosis of Lyme Borreliosis
2005
Immunochemical and immunological analysis of European Borrelia burgdorferi strains
1986
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Abundance of wild rodents, ticks and environmental risk of Lyme borreliosis: a longitudinal study in an area of Mazury Lakes district of Poland.
2006
The Asthma Epidemic
2006 Standout
Common themes in microbial pathogenicity revisited
1997 Standout
Evaluation of a New Culture Medium for Borrelia burgdorferi
2000
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Antimicrobial activity of two bactenecins against spirochetes
1993
Ecological Impacts of Deer Overabundance
2004 Standout
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease
1988
Comparison of In Vitro Activities of Ketolides, Macrolides, and an Azalide against the SpirocheteBorrelia burgdorferi
2003
Clinical Findings for Patients with Lyme Borreliosis Caused byBorrelia burgdorferiSensu Lato with Genotypic and Phenotypic Similarities to Strain 25015
1997
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children
1999
Clinical Manifestations and Diagnosis of Lyme Borreliosis
2009
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents
1987
Long-term protection of mice from Lyme disease by vaccination with OspA
1992
Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets.
1993
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
2019 StandoutNobel
The Biological and Social Phenomenon of Lyme Disease
1993 Science
Reinfection in erythema migrans disease
1986
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
1986
Follow-up of Patients Treated with Oral Doxycycline for Lyme neuroborreliosis
2001
Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia
2012 StandoutNobel
Lyme disease: a growing threat to urban populations.
1994
Cutaneous pseudo-T-cell lymphomas.
1991
Lack of Cardiac Manifestations among Patients with Previously Treated Lyme Disease
1998
Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis
1996
Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis
1992
Comparison of Culture-Confirmed Erythema Migrans Caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia
1999
Isolation of Antigenic Components from the Lyme Disease Spirochete: Their Role in Early Diagnosis
1987
The Clinical Evolution of Lyme Arthritis
1987 Standout
Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria
1988
Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
1993
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit
1986
Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
1989 Standout
Lyme arthritis: Clinical features, serological, and radiographic findings of cases in Germany
1986
Works of A. Hovmark being referenced
The spirochetal etiology of erythema chronicum migrans Afzelius
1984
Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
1992
Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays
1985
The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer
1984
Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation
1997
Classification, geographic variations, and epidemiology of Lyme borreliosis
1993
Early and Late Cutaneous Manifestations in Ixodes‐borne Borreliosis (Erythema Migrans Borreliosis, Lyme Borreliosis)a
1988
First isolations of Borrelia burgdorferi from rodents collected in Northern Europe
1988
Tick-borne Borreliosis and Facial Palsy
1988
Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment
2002
Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans.
1991
An in vivo and in vitro study of cell-mediated immunity in atopic dermatitis
1975
Polyneuropathy in late Lyme borreliosis ‐ a clinical, neurophysiological and morphological description
2000
Expression of HLA‐DQ Antigens on Keratinocytes in Borrelia Spirochete‐Induced Skin Lesions
1986
Successful Cultivation of Spirochetes from Skin Lesions of Patients With Erythema Chronicum Migrans Afzelius and Acrodermatitis Chronica Atrophicans
1985
Tick-borne spirochetes as a cause of facial palsy
1985
Lyme borreliosis: aspects of tick-borne Borrelia burgdorferi infection from a dermatologic viewpoint.
1990
Joint and bone involvement in Swedish patients with Ixodes ricinus-bomt Borrelia infection
1986
Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients
1986
Cutaneous Manifestations in Ixodes‐borne Borrelia Spirochetosis
1987
Acrodermatitis Chronica Atrophicans—A Spirochetosis Clinical and Histopathological Picture Based on 32 Patients; Course and Relationship to Erythema Chronicum Migrans Afzelius
1986
Comments on the course and classification of Lyme borreliosis.
1991
Polymerase chain reaction for detection ofBorrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis
1995
IgG subclasses of specific antibodies in Ixodes ricinus-borne borreliosis.
1987
The spirochetal etiology of lymphadenosis benigna cutis solitaria
1986
[Diagnosis of Borrelia infections is an all-year-round problem as the serological examination of the cases from 1985 shows].
1986
Erythema chronicum migrans afzelius in sweden. A study on 231 patients
1986
Antibodies to Borrelia Spirochetes in Sera from Swedish Cattle and Sheep
1986